Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 18.950.37-16.3434.26136.36

What is the latest EBIT Growth ratio of EMCURE PHARMACEUTICALS ?

The latest EBIT Growth ratio of EMCURE PHARMACEUTICALS is 18.95 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202518.95
Mar20240.37
Mar2023-16.34
Mar202234.26
Mar2021136.36

How is EBIT Growth of EMCURE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 18.95
5,021.62
Mar2024 0.37
Positive
Mar2023 -16.34
Negative
Mar2022 34.26
-74.88
Mar2021 136.36 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹28,742.4 Cr 3.1% -0.8% 18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

3.1%

-0.8%

18.8%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses